Mark Cuban Cost Plus Drug Co. has entered into an agreement with IBSA Pharma to sell Tirosint, a medication for hypothyroidism. It will be the first brand-name drug offered by Mr. Cuban’s pharmacy.
Nearly 1.9 million Americans received prescriptions for the proton-pump inhibitor omeprazole, the most frequently prescribed gastroenterology medication in 2021, according to 2022 data from Definitive Healthcare.
Rochester, N.H.-based Frisbie Memorial Hospital will be allowed to discontinue labor and delivery services after a $2.75 million settlement agreement, Foster’s Daily Democrat reported March 7.
Ophthalmic biopharmaceutical company TearSolutions has established a strategic advisory board, appointed five opinion leaders to its medical advisory board and promoted James Cook to chief development officer.
Personalized, digital tools are the future — and the now — of hospital and health system marketing, while “the days of general, mass marketing are coming to a close,” said Tim Shonsey, vice president of enterprise marketing for Salt Lake City-based Int…
After the last few years of guiding organizations through the pandemic and facing extreme financial and operational challenges this year, health system CEOs are turning to a tried-and-true leadership tactic to balance growth and innovation with the rea…